[Editorial] UK PrEP decision re-ignites HIV activism

April 9, 2016

The Lancet 387, 10027 (2016)

Author: The Lancet

On March 21, NHS England announced that, contrary to expectation, it will not proceed with a scale-up of pre-exposure prophylaxis (PrEP) for prevention of HIV infection among at-risk populations. Saying it was “not responsible for commissioning HIV prevention services”, the agency effectively dropped plans to hold public consultations and instead tepidly said it would work with local health authorities to consider how to make the anti-HIV drugs more widely available. Few other details were offered.